mental disorders
Othermental disorders
NCT Number: NCT01767207
Patients referred to pediatric rehabilitation services have often cognitive deficits/intellectual disabilities.Neurocognitive assessment is, hence, important when designing treatment plans.
Children and adolescents with cognitive deficits and intellectual disabilities (ID) have a high risk of developing mental health problems. There is lack of knowledge about such comorbid mental disorders in the health service. There are also few validated instruments for assessing mental disorders among children and adolescents with cognitive deficits and ID both in Norway and abroad.
The main aims of the current multicentre study are to:
Investigate psychometric properties of different psychiatric instruments for children and adolescents. Investigate change and stability of symptoms over time. Investigate user satisfaction. The study will include Pediatric Rehabilitation Services at hospitals in Tromsø, Hammerfest and Bodø and will include in total 320 patients aged 4 to 18. We will use information from parents, teachers and patients, in addition to clinician-rated measures. Patients will be assessed at intake and after six months. We have conducted a pilot study in the period from 2012 to 2013.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Observational
Finnmarkssykehuset (The Finnmark Hospital Trust), Hammerfest, Norway
(DAWBA) and a symptom measure (SDQ) in clinical samples of children and
adolescents with cognitive deficits and intellectual disabilities. We will
investigate the instruments' reliability and convergent validity with the
Aberrant Behavior checklist (ABC), the DBC and the Social Responsiveness
Scale (SRS), in addition to the clinician-rated severity of children's mental
health problems measured with the CGAS and HoNOSCA.
months. We will investigate prevalence rates and indicators of disorder
severity (comorbidity and persistence), including risk factors (socioeconomic
status, parenting styles).
Rehabilitation Services.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Exclusion criteria
-
mental disorders
screening for mental disorders
Time frame: Within the first or second day the patient is undergoing an assessment at the hospital
The Development and Well Being Assessment (DAWBA) is a package of interviews, questionnaires and rating techniques designed to generate psychiatric diagnoses on 5-17 year old according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) and Diagnostic and Statistical Manual of Mental Disorders(DSM-IV).
Time frame: within 6 months after the initial assessment
The Development and Well Being Assessment short-version is re-administered 6 months after taking part in the study (i.e., the basic outcome measure)
Time frame: Within the first or second day the patient is undergoing an assessment at the hospital
Aberrant Behavior Checklist
Time frame: Within the first or second day the patient is undergoing an assessment at the hospital
Health of the Nation Outcome Scales for Children and Adolescents
Time frame: Within the first or second day the patient is undergoing an assessment at the hospital
Children's Global Assessment
Time frame: Within the first or second day the patient is undergoing an assessment at the hospital
Social Responsiveness Scale
University Hospital of North Norway
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04606966
Autism Spectrum Disorder, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT02793271
Behavior, Behavioral Symptoms
Bharatpur, Chitwan, Nepal
View Trial DetailsNCT05318976
Alzheimer Disease, Brain Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT07643714
Behavior, Behavioral Symptoms
Kahramanmaraş, Turkey (Türkiye)
View Trial Details